| Protocol No. | Title | Status |
| 05-0226-04 | Arizona Lymphoid Tissue and Blood Repository (ALTBR) | Open |
| 06-0101-03 | Sentinel Lymph Node Working Group Data Acquisition Project | Open |
| 08-0610-04 | Tracking Suspicious Skin Lesions | Open |
| 11-0297-04 | Infant Sun Safety Study | Open |
| 11-0571-10 | E1609 A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon a-2b for Resected High-Risk Melanoma | Open |
| 12-0229-04 | Skin Cancer Prevention Program Biorepository | Open |
| 20100922 | An Extension Protocol to Evaluate the Efficacy and Safety of Extended Use Treatment with OncoVEXGM-CSF for Eligible Melanoma Patients Participating in Study 005/05 | Open |
| 20120611 | A Multicenter, Double-blind, Placebo-controlled, Adaptive Phase 3 Trial of POL-103A Polyvalent Melanoma Vaccine in Post-resection Melanoma Patients with a High Risk of Recurrence | Open |
| 20120924 | An open-label, multicenter, Phase II study of continuous oral vemurafenib in patients with locally-advanced, unresectable, stage IIIC or metastatic melanoma and activating exon 15 BRAF mutation other than V600E | Open |
| 20121298 | Randomized, Phase II Study of MK-3475 versus Chemotherapy in Patients with Advanced Melanoma | Open |
| 20121932 | A multicentre, open label, randomized Phase II trial of the MEK inhibitor pimasertib or dacarbazine in previously untreated subjects with N-Ras mutated locally advanced or metastatic malignant cutaneous melanoma
| Open |
| R0306 | Non-Steroidal Anti-Inflammatory Drugs and Melanoma-- A Pooling Study | Open |